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DOI: 10.1039/c2ay05818aThe present work describes an analytical platform based on a multipumping flow injection analysis
(MPFS) technique combined with in-line solid-phase extraction (SPE). The flow network has been
tested with the determination of quinine in biological samples using fluorometry as the detection
technique. Amberlite XAD-4 resin has been used as a solid phase and the implementation of a pH
control strategy resulted in a simple and environmental approach for the preconcentration of quinine.
Two solenoid valves allowed the deviation of the flow towards the resin column to carry out SPE
procedures. The influence of parameters such as concentration, flow rate and volume of the different
solutions on the sensitivity and performance of the MPFS was studied. Dynamic calibration ranges
(0.78–150 ng mL1) for quinine determination were applied by using a variable sample volume (120–
1000 mL). The developed methodology provided high relative extraction recoveries from human urine
samples (85–115%). The proposed automatic methodology turns out to be very efficient and sustainable
compared to the available procedures and it could prove to be an attractive alternative tool to perform
in-line sample pre-treatment and subsequent direct determination of relevant organic compounds in
pharmaceutical and clinical analyses.1. Introduction
Flow techniques in general are recognized nowadays as powerful
and useful methodologies for the automation of analytical
procedures in many areas. The inherent advantages of flow
techniques such as versatility, simplicity and low cost make these
procedures a valuable choice for the analysis of complex
matrixes, coupled to sample pre-treatment devices and different
detection systems.1
Multi-pumping flow systems (MPFSs) were recently proposed
by Lapa et al.2 and are based on the use of a series of individual
small size solenoid-actuated micro-pumps that are controlled by
a computer, strategically positioned in the flow manifold, which
are accountable for sample–reagent insertion, propelling and
commutation, conditioning the establishment and subsequent
detection of the reaction zone. Being the only active components
of the flow manifold, they enable miniaturized and compact flow
systems to be developed, with a higher degree of simplicity andaREQUIMTE, Departamento de Quımica, Faculdade de Farmacia da
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This journal is ª The Royal Society of Chemistry 2012improved operational characteristics and a straightforward run-
time control of important analytical variables.
In clinical and pharmaceutical analyses, it is almost imperative
to carry out sample manipulation and pre-treatment stages
before the measurement step. Furthermore, a direct in-line
coupling of the sample preparation procedure to the analytical
system minimizes sample handling and thereby the risk of
contamination or loss of analyte, making the automation of the
whole process possible.
One of the most widely used sample pre-treatment procedures
is automated solid-phase extraction (SPE),3 which employs an
appropriate solid- or liquid-extraction material attached on
a suitable support for which MPFS is ideally suited. SPE has
been widely used in flow analysis since it allows trace enrichment
(concentration), matrix simplification and medium exchange.3–5
In spite of the new trends in SPE, the use of packed columns with
conventional resin, a scarcely exploited feature inMPFSs, should
be pointed out. In fact, the mechanical action of pulsed flows in
these systems enabled a chaotic pattern that maintains the resin
particles in circulating motion.6 This way it was possible to
minimise some of the drawbacks usually associated with the
utilisation of packed columns, such as backpressure effects and
preferential pathways.
In the present work, the MPFS-SPE assembly was applied to
the determination of quinine in biological samples. Quinine is
a natural occurring cinchona alkaloid that has been widely used
































































View Article Onlinecalled malaria.7 It is also present in other pharmaceutical
formulations due to its antipyretic, analgesic and anti-inflam-
matory properties. In the food industry, quinine is also utilized as
a flavouring agent in soft drinks such as tonic water due to its
bitter taste. However, quinine is a potentially toxic drug. The
typical syndrome of quinine side effects is called cinchonism that
is mild in usual therapeutic dosage or severe in larger doses.
Quinine side effects include thrombocytopenia, visual, auditory,
gastrointestinal, cardiovascular and neurological effects, such as
nausea, headache and fever, disturbed vision, renal failure, chest
pain and asthma.8 Its determination is therefore of utmost
importance in clinical chemistry, in different body fluids, for
proper treatment of malaria cases. In this sense, several methods
have been reported for the determination of quinine in human
biological fluids (Table 1). These methods include high-perfor-
mance liquid chromatography (HPLC) procedures using
normal9 or reversed-phase columns after liquid–liquid/solid
extraction of the drug and either ultraviolet10 or fluorescence
detection.11,12 Chemiluminometric,13,14 capillary electropho-
resis,15 gas chromatography16 and thin layer chromatography17
methods have also been developed. However, some procedures
involve high-cost equipment and are time consuming with low
sampling throughput, requiring sample pre-treatment (including
most of the time extraction with organic solvents). Indeed,
although sample pre-treatment is an important stage in most
methodologies it is completely separated from the quantification
procedure (Table 1). Consequently, the determination of quinine
in biological fluids could clearly benefit from a simple, rapid,
methodology with an in-line sample pre-treatment step with
exact time control of reaction conditions.
2. Materials and methods
2.1. Reagents and solutions
Water from a Milli-Q system was used for the preparation of all
solutions, and all chemicals were of analytical reagent grade.
The stock quinine hydrochloride dihydrate solution contain-
ing 100 mg L1 was obtained by accurately weighing the
appropriate mass and dissolving it in 100 mL. An intermediateTable 1 Comparison between different methodologies for quinine assay in b
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1682 | Anal. Methods, 2012, 4, 1681–1686stock solution containing 10 mg L1 of quinine and 0.10 mol L1
NaOH was also prepared. The working standards were prepared
daily by careful dilution of the previous solution in 0.10 mol L1
NaOH. In the MPFS, the carrier was 0.05 mol L1 H2SO4
solution. Amberlite XAD-4 resin was purchased from Fluka.
Urine samples were obtained from healthy adult volunteers.
The urine samples were filtered (Corning filters, 0.20 mm),
the pH was adjusted to 13.0 with NaOH and diluted 1 : 20 with
0.1 M NaOH before insertion in the multipumping flow system.
2.2. Extraction column preparation
Initially, 50 mg of Amberlite XAD-4 resin was suspended in
water and some drops of ethanol. After that, this suspension was
packed in an acrylic column (4 cm length; 3 mm inner diameter).
Two filters of 35 mm pore size (Mobicol M 1002, MoBiTec) were
placed at both ends of the column to entrap the resin. The resin
particles were then sequentially washed using water : methanol
(2 : 1 v/v), methanol, water, 0.01 mol L1 H2SO4, 0.1 mol L
1
NaOH and water, being inserted into the flow system.
2.3. Apparatus
The flow manifold comprised four solenoid micropumps
(Ref. 090SP Bio-Chem Valve Inc.), which were fixed displace-
ment diaphragm pumps, dispensing a volume of 10 mL per
stroke, and three solenoid commutation valves (NResearch 161
T031) to that allows the access to two different pathways. These
micropumps (approximately 5 cm in length) are diaphragm
pumps, operated by a solenoid, in which the diaphragm is
maintained, closed by means of an inner spring mechanism.
When voltage is applied, the solenoid coil is activated in order to
open the diaphragm. This opening action permits the fluid to be
drawn into the pump chamber. The fluid is dispensed from the
pump by dropping the applied voltage, thus de-energizing the
solenoid coil; the spring then forces the diaphragm back to the
closed status.
A LabAlliance fluorescence detector LC 305 equipped with an
8 mL flow-cell was used as the detection system and the excitation
and emission monitoring wavelengths were set at 250 andiological samples
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View Article Online450 nm, respectively. Analytical signals were recorded on a strip
chart recorder (Linseis, L250E) or acquired.
Automatic control of the analytical system was accomplished
by means of a Pentium-based microcomputer and software,
developed using Microsoft QuickBasic 4.5. A lab-made elec-
tronic interface using a CoolDrive power drive board (NRe-
search Inc.) was used to activate the solenoid of micropumps
through the LPT1 computer port.2.4. Manifold and flow procedure
All connections were made of Omnifit (Cambridge, UK) PTFE
tubing with 0.8 mm i.d. unless stated otherwise. Gilson (Villiers-
le-Bel, France) end-fittings, connectors and confluences were
also used.
Lab-made acrylic extraction columns of different lengths and
diameters were tested.18 The system components were arranged
as shown schematically in Fig. 1.
The micropump MP1 was responsible for insertion and
propelling of the sulfuric acid solution, which was the eluent;
MP2 was used for inserting the hydroxide sodium solution, which
was the regenerating solution; MP3 and MP4 were used for
inserting the standard or sample and cleaning water solutions,
respectively.
The analytical cycle (Table 2) started by actuating MP2,
inserting 2 mL of hydroxide sodium solution in the analytical
path, passing through the column to regenerate it, at a fixed pulse
time of 0.3 s (0.15 s activation + 0.15 s deactivation), which
corresponds to a pulse frequency of 200 Hz, giving a flow rate
equal to 2.00 mLmin1 (Step 1). Thereafter, the micropumpMP2Fig. 1 Schematic depiction of the proposed automatic setup for deter-
mination of quinine in biological samples: MPi – 10 mL solenoid micro-
pumps; C – confluence point; D – fluorometric detector (lexcitation ¼ 250
nm; lemission ¼ 450 nm); svi – solenoid commutation valves; EC –
extraction column; W – waste; eluent solution (0.05 mol L1 H2SO4);
regeneration solution (0.1 mol L1 NaOH); and cleaning solution (H2O).
This journal is ª The Royal Society of Chemistry 2012was switched off, and, by actuation of the micropump MP3 at
a fixed pulse time of 2 s (1 s activation + 1 s deactivation), the
sample solution was inserted into the column filled with
Amberlite XAD-4 resin (Step 2). Then, the micropumpMP4 was
activated, inserting 2 mL of water solution to wash the column
and then removing matrix remains, at a pulse time of 0.3 s (Step
3). The last step is the elution, by actuating the micropump MP1
that propelled 3 mL of sulfuric acid solution that carried the
analyte retained towards the detector, at 2.00 mL min1, after
which the content of the flow cell was washed out, and thus
establishing the baseline (Step 4).3. Results and discussion
3.1. Design and optimization of the flow system for
determination of quinine
The optimum conditions of the MPFS for the determination of
quinine in human urine samples were studied by the univariate
approach with the influence of several parameters on its working
characteristics being evaluated. The studied range of parameters
as well as the final conditions selected are summarised in Table 3.
In the present paper, we aimed to determine quinine in bio-
logical samples, namely in human urine samples. As quinine
exhibits strong native fluorescence, it could be detected without
derivatization directly by fluorometry. To extract it from the
biological matrix an in-line pre-concentration unit was intro-
duced using a column filled with Amberlite XAD-4 resin. This is
an inexpensive resin that is a non-ionic crosslinked polymer,
stable throughout the pH range of 1–13. These characteristics
enable us to perform the retention of target analyte in the
Amberlite XAD-4 sorbent under alkaline conditions (pH ¼ 13),
using 0.10 mol L1 NaOH as the carrier. Standards and samples
were also alkalinized to this pH. This was necessary to promote
the retention of quinine which is predominantly in the non-ionic
form at high pH values (Fig. 1, bottom). The pH shift towards
acidic values which promoted the ionization of the retained
quinine compound and thus its subsequent desorption from the
non-ionic crosslinked polymer resin was carried out with sulfuric
acid at a pH near the maximum emission of quinine and where
the intrinsic fluorescence of some possible interferents such as
chloroquine is almost null.19
The influence of the eluting agent concentration was then
tested between 0.001 and 0.10 mol L1. For quinine concentra-
tions between 12.5 and 50 ng mL1, calibration curves were
established and an increase in sensitivity up to 0.05 mol L1
H2SO4 was noticed (Fig. 2). The differences obtained with higher
concentrations (only of about 0.5% for 0.10 mol L1 H2SO4)
did not justify its use. Therefore, for further experiments
a 0.05 mol L1 H2SO4 solution was chosen.
With this proper elution process, the adsorbed quinine was
rapidly eluted, because of the high rate of diffusion of the eluting
agent through the porous structure of the beads. In order to
enhance the determination frequency, the influence of the eluent
flow rate in the reaction was evaluated using the above-defined
conditions. Flow rate values between 1.0 and 2.0 mL min1 were
tested and similar values of sensitivity were attained. Further-
more, an elution volume equal to 3.0 mL was sufficient to ensure
the complete desorption of the quinine retained to the sorbentAnal. Methods, 2012, 4, 1681–1686 | 1683
Table 2 Protocol sequence for determination of quinine in urine samples
Step MP1 MP2 MP3 MP4 Pulses Time (s)
Flow rate
(mL min1) Description
1 OFF ON OFF OFF 200 0.30 2.0 Regeneration of the column with 2 mL of
NaOH 0.1 M
2 OFF OFF ON OFF 12 2.0 0.3 Insertion of the sample/quinine standard
through the column
3 OFF OFF OFF ON 200 0.30 2.0 Cleanup of the column and removal of
matrix remains by propulsion of 2 mL of
water
4 ON OFF OFF OFF 300 0.30 2.0 Elution of retained quinine towards the
detector with 3 mL of H2SO4 0.05 M
Fig. 2 Influence of the sulfuric acid concentration on the elution rate
and subsequent sensitivity of the presented method. Experimental
































































View Article Onlineused. Flow rates higher than 2.0 mL min1 were not applied to
avoid the possible pressure build-up. Then, the value chosen was
2.0 mL min1. In a similar way, the volumes and flow rates of the
regeneration and cleanup steps (Table 2, Steps 1 and 3, respec-
tively) were evaluated with the aim of increasing the determina-
tion rate without compromising the performance of the method.
The corresponding volumes used should be adequate to promote
an effective regeneration of the resin (Table 2, Step 1) and the
cleanup of the biological matrix that remained after the insertion
of the sample (Table 2, Step 3) without the induction of a pre-
elution of the analyte. Therefore, the corresponding volumes that
passed through the column were equal to 2 mL. The flow rates of
the regeneration and cleanup steps were evaluated and then fixed
at 2.0 mL min1, as these flow rates did not practically affect the
sensitivity of the method.
The sample volume was one of the most important parameters
of the developed methodology in terms of the sensitivity of the
determination but also in terms of sampling strategy. Sample
volumes between 120 and 1000 mLwere tested and the calibration
curves (fluorescent intensity (FI) ¼ 0.1437 (0.0081) Cquinine (ng
mL1)  0.2378 (0.6509), R2 ¼ 0.9968; FI ¼ 0.5742 (0.0457)
Cquinine (ng mL
1) + 0.1547 (1.994), R2 ¼ 0.9952; FI ¼ 0.8346
(0.0415) Cquinine (ng mL1) + 0.1231 (0.8467), R2 ¼ 0.9975)
obtained showed linear responses in concentration ranges of
6.25–150 ng mL1, 3.12–100 ng mL1 and 0.78–50 ng mL1 for
sample volumes of 120, 500 and 1000 mL, respectively. Thus, the
developed method provided a wide dynamic concentration range
achieved by just changing the sample volume (Step 2, Table 2). A
volume of 120 mL was selected for further experiments as it led to
a higher sampling frequency and the sensitivity achieved enabledTable 3 Range of values used in the study of system parameters and
selected values for its operation







Eluent flow rate (mL
min1)
1.0–2.0 2.0
Loading flow rate (mL
min1)
0.25–2.0 0.3
Column dimensions i.d. 2–4 mm; length 3–4
cm
i.d. 3 mm; length 4
cm
Sample volume (mL) 120–1000 120
1684 | Anal. Methods, 2012, 4, 1681–1686quinine determination within the normal quinine ranges present
in human urine.
The influence of other factors affecting the quinine pre-
concentration efficiency was examined, namely the column
dimensions, the loading flow rate and the nature of the resin,
besides the key elution operation.
Using the conditions described before, studies were performed
with three different columns: two columns with internal diame-
ters of 3.0 and 4.0 mm and lengths of 4.0 cm and one column with
an internal diameter of 2.0 mm and a length of 3.0 cm. The slope
value obtained for the 3.0 cm column was about 61% of that
obtained for the 4.0 cm column with 3.0 mm inner diameter. This
difference could be attributed to the lower quantity of the mac-
roreticular resin used in the 3.0 cm column resulting in a lower
quinine retention rate. The internal diameter of the column was
also varied, keeping the column length at 4.0 cm. Moreover, the
sensitivity obtained for the 4.0 mm internal diameter column was
about 86% of that obtained when using the 3.0 mm inner
diameter column. Perhaps, in spite of achieving multiple bead
pores available at the time of the arrival of the analyte, as
a consequence of using a higher quantity of resin, there was
a higher dead volume which carried out a considerable sample
dispersion increase and consequently an analytical signal
decrease. Therefore, the column with 3.0 mm diameter and
4.0 cm length was chosen for further studies.
To avoid the formation of a liquid gap at the top of the column
and the consequent pressure build-up, the operations of loading
and elution were performed in opposite directions. Therefore, the
connections between the MP1, responsible for propelling the
eluent, and the extraction column and between the MP3,
responsible for the loading the sample, and the extractionThis journal is ª The Royal Society of Chemistry 2012
Fig. 3 Variation of the analytical signal magnitude (%) by changing the
loading flow rate (,) and theMP3 pulse time (A).Conditions: aspiration
of 120 mL of sample volume.
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View Article Onlinecolumn were placed in different commutation valves (sv1 and sv2,
respectively). The influence of the loading flow rate in the
analytical signal was tested between 0.25 and 2.0 mL min1 as
shown in Fig. 3. Considering the starting conditions of 0.6
seconds for the pulse time, which corresponds to a loading flow
rate of 1 mL min1, it was verified that for low pulse times (e.g.
0.3 s) (and hence higher flow rates), the analytical signal declined
(Fig. 3). However as the pulse time increased and consequently
the loading flow rate decreased the analytical signal incremented
up to a pulse time of 2 s. This could be explained by a longer
residence time in the column with the resin and consequently
favourable conditions created for the analyte that reached the
bead pores and become entrapped within the sorbent, without
increasing the sample dispersion. The difference obtained with
higher pulse times (only of about 2% for a pulse time of 2.4 s) did
not substantiate its use. As a result, a loading flow rate of 0.3 mL
min1 (corresponding to a 2 s pulse time) was adopted.
Finally, a comparative study was carried out using the
Amberlite XAD-2 resin, which has been widely used to adsorb
organic compounds even from biological matrices.20 For quinine
concentrations up to 50 ng mL1, calibration curves were then
established (FI ¼ 0.0780 (0.0120) Cquinine (ng mL1)  0.0337
(0.3426),R2 ¼ 0.9975; FI¼ 0.1443 (0.0351)Cquinine (ng mL1)
+ 0.2506 (1.006), R2 ¼ 0.9936) using the Amberlite XAD-2 and
XAD-4 resins, respectively, both packed in acrylic columns (4 cm
length; 3 mm inner diameter). It was verified that the slope value
obtained for the column filled with Amberlite XAD-4 was about
2 times higher than that obtained when using the Amberlite
XAD-2.
60 69 (1) 114.9 1.9
Urine 2 30 34 (2) 113.7 5.5
36 33 (1) 91.4 3.7
42 38 (1) 90.9 3.7
Urine 3 30 33 (1) 109.1 3.1
42 38 (1) 89.9 1.6
75 75 (1) 99.5 0.5
Urine 4 36 33 (1) 91.1 2.8
48 42 (1) 87.1 1.4
62.5 61.5 (3.0) 98.3 4.4
Urine 5 36 34 (2) 94.9 6.5
46 49 (2) 106.6 5.1
100 98 (2) 97.5 2.2
Urine 6 48 48 (1) 100.5 2.0
50 49 (1) 98.8 2.4
87.5 79.3 (1.1) 90.6 1.0
Urine 7 15 16 (1) 104.0 6.5
60 52 (3) 87.3 6.3
90 95 (1) 105.6 1.53.2. Evaluation of the method and its application to urine
samples
Calibration curves for urine were constructed by transferring
aliquots of the standard solutions of quinine into a blank pooled
drug-free urine sample to give final concentrations within the
range of concentrations studied. A blank quinine-free urine
sample was also considered.
Under the above-defined optimal conditions, the calibration
curve (FI ¼ 0.1331 (0.0096) Cquinine (ng mL1) + 0.3909
(0.5936), R2 ¼ 0.9948) obtained showed linear responses in
concentration ranges of 12.5–150 ng mL1. A decrease in sensi-
tivity of about 7% was noticed when compared with the cali-
bration of quinine standards in aqueous medium.This journal is ª The Royal Society of Chemistry 2012The detection limit was estimated21 as three times the standard
deviation of 10 blank measurements and a value of 9.7 ng mL1
was obtained. Furthermore, the developed methodology can be
particularly interesting for the analysis of samples that demand
lower detection limits by just increasing the sample volume.
The repeatability of the flow procedure was estimated by
calculating the relative standard deviation (R.S.D.) from 10
consecutive injections of urine samples. Values of 1.7% for
12.5 ng mL1 quinine and 1.4% for 100 ng mL1 quinine spiked
urine samples were obtained, showing small differences over
a significant range of concentrations. The time required for
a complete analytical cycle is the sum of the time required for
each step and for proper micropumps activation and deactiva-
tion. Almost 260 s were required to complete an analytical cycle
and hence the determination rate equated to about 14 determi-
nations per hour. Therefore, the present flow-solid-phase
extraction technique represents a noteworthy improvement in
the efficiency and quickness when compared to the available
procedures, where the sample pre-treatment besides being time-
consuming is almost completely separated from the analysis
procedure.
In order to validate the proposed method for the determina-
tion of quinine in biological fluids, analyses of spiked urine
samples were performed. Results of recovery studies of quinine
for spiked urine samples within the normal quinine ranges
present in these biological fluids are given in Table 4. Each value
represents the mean of three measurements carried out. It was
verified from these studies that quinine recovery varied in the
range 85–115% for all samples studied over the entire range
of concentration and the majority of RSD values were lower
than 5%.
For comparison purposes, a linear relationship CMPFS
(ng mL1) ¼ C0 + SCSPIKING (ng mL1) was established. The
equation found was CMPFS ¼ 0.0006 (0.0047) + 0.9917
































































View Article Onlineof the 95% confidence intervals. From these figures it is clear that
the estimated intercept and slope do not differ significantly from
the values 0 and 1, respectively. Thus, there is no evidence of
systematic differences between the two sets of results obtained by
the proposed methodology and the corresponding concentration
levels of spiked urine. Furthermore, when a paired t-test21 was
performed on the data obtained for quinine content, a t value of
1.14 was obtained. The comparison between that value and the
critical value tabulated t ¼ 2.08 illustrates the absence of statis-
tical differences at the 95% confidence level for the results of the
concentration of spiked urine and the corresponding concen-
tration found.
4. Conclusions
The proposed miniaturized methodology was successfully
applied to the determination of quinine in human urine, with
results comparable to those obtained by the available proce-
dures. It combines the automatic flow methodology with an in-
line preconcentration unit in order to extract the analyte from the
biological sample, allowing its determination in a fully aqueous
environment. Therefore this strategy offered an environmentally
friendly alternative to the organic solvent extraction usually
performed.10,11,19,22,23
Compared to other previously described methods for quinine
determination in biological samples,22 the developed method did
not explore the quinine metabolism. In fact, quinine is eliminated
in urine mainly as unchanged drug and its major metabolite,
3-hydroxyquinine, represents only 14%.24 Additionally, some
high-performance liquid chromatography methodologies also
enabled the determination of the synthetic anti-malarial drug
chloroquine.11,12,23 However, in recent years new outbreaks of
chloroquine-resistant strains of malaria are guiding the driving
forces behind the renewed interest in the use of the naturally
occurring alkaloid quinine in the treatment of this parasitical
disease.19 Recently, two flow injection analysis methods with
chemiluminometric detection for the determination of quinine
were developed13,14 with detection limits identical to those ach-
ieved here. However the former13 requires an off-line organic
solvent liquid–liquid extraction before the introduction to the
flow system, besides the use of the organic solvent extractor as
a carrier, and the latter one14 comprises a protein precipitation
step and subsequent centrifugation within the sample pre-
treatment.
The proposed method provided recovery rates from urine
samples in the range from 85 to 115%, which means that their
extraction efficiency is very satisfactory. These values are
comparable and even higher than those reported in the literature.
The fluorometric determination of quinine, implemented in
a fully automatic controlled multipumping flow system, resulted
in a simple, low cost, sensitive, and precise methodology that1686 | Anal. Methods, 2012, 4, 1681–1686could be a choice for implementation in clinical laboratories in
routine assessment as a reliable analytical alternative to the
available procedures.
Finally, the proposed automatic methodology could be
a valuable strategy for the screening of other organic compounds
from biological matrices.
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